Further observations on depolarizing neuromuscular block: the so-called phase II block.
D000818:Animals; D003650:Decamethonium Compounds / Q000494:pharmacology*; D003964:Diaphragm / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009045:Motor Endplate / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D009388:Neostigmine / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents; D010791:Phrenic Nerve / Q000187:drug effects; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D013390:Succinylcholine / Q000494:pharmacology*
D003650:Decamethonium Compounds; D009467:Neuromuscular Depolarizing Agents; D009388:Neostigmine; D013390:Succinylcholine; D011188:Potassium